Study title:
Neidhardt-M, Bailey-C-C, Gnekow-A, Kleihues-P, Michaelis-J, Wellek-S.
(Medulloblastoma therapy studies MBL 80 and MED 84 of the Society of Pediatric Oncology and the Societe Internationale d'Oncologie Pediatrique (SIOP)).
Klinische Paediatrie {Klin-Padiatr} 1987 May-Jun, VOL: 199 (3), P: 188-92, ISSN: 0300-8630.Neidhardt-M, Bailey-C-C, Gnekow-A, Kleihues-P, Michaelis-J, Wellek-S.
(Medulloblastoma therapy studies MBL 80 and MED 84 of the Society of Pediatric Oncology and the Societe Internationale d'Oncologie Pediatrique (SIOP)).
Klinische Paediatrie {Klin-Padiatr} 1987 May-Jun, VOL: 199 (3), P: 188-92, ISSN: 0300-8630.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|